Coronavirus Disease (COVID-19)
Revisions

Revisions

June 21, 2021

  • Clinical Management and Treatment: Updated recommendations for therapeutic anticoagulation and venous thromboembolism prophylaxis
  • Clinical Management and Treatment: Revised tocilizumab dosing

May 6, 2021

  • Testing & Clinical Management and Treatment: Revised Clearance Criteria for Lab Confirmed COVID-19 Inpatients section

April 23, 2021

  • Clinical Management and Treatment: Revised Pharmacologic Management by Disease Severity section
  • Clinical Management and Treatment: Added recommendations for therapeutic anticoagulation and venous thromboembolism prophylaxis
  • Clinical Management and Treatment: Added recommendations for inhaled budesonide
  • Clinical Management and Treatment: Added recommendations for colchicine

April 12, 2021

  • Clinical Management and Treatment: Revised corticosteroid section
  • Clinical Management and Treatment: Revised tocilizumab and sarilumab section
  • Clinical Management and Treatment: Revised antibiotics section

January 13, 2021

  • Clinical Management and Treatment: Added Pharmacologic Management by Disease Severity to summarize treatment options
  • Clinical Management and Treatment: Added information for tocilizumab
  • Clinical Management and Treatment: General clean-up of section

December 3, 2020

  • Updated microbiology section
  • Clinical Management and Treatment: Updated antibiotics section
  • Clinical Management and Treatment: Added Pregnancy and Breastfeeding section
  • Clinical Management and Treatment: Added information for remdesivir

July 29, 2020

  • Updated microbiology and AGP guidance
  • Updated diagnosis section
  • Updated testing guidance
  • Added corticosteroids to treatments section
  • Revised Oseltamivir section
  • Added information on Remdesivir

April 6, 2020

  • Infection Prevention and Control: Updated language around aerosol generating procedures
  • Testing: Updated to most recent testing guidelines for sample types